Trials / Recruiting
RecruitingNCT05874674
The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study
The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Diathesis Undergoing Hemodialysis: A Pilot Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Wonju Severance Christian Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Comparison nafamostat and low molecular weight heparin among dialysis patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nafamostat Mesylate | Comparison effect of nafamostat and cnoxan |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
- First posted
- 2023-05-25
- Last updated
- 2024-07-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05874674. Inclusion in this directory is not an endorsement.